Fluvoxamine
"Fluvoxamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.
| Descriptor ID |
D016666
|
| MeSH Number(s) |
D02.092.570.665.250
|
| Concept/Terms |
Fluvoxadura- Fluvoxadura
- Merck dura Brand of Fluvoxamine Maleate
Fluvoxamin-ratiopharm- Fluvoxamin-ratiopharm
- Fluvoxamin ratiopharm
- Ratiopharm Brand of Fluvoxamine Maleate
- ratio-Fluvoxamine
- ratio Fluvoxamine
Luvox- Luvox
- Solvay Brand of Fluvoxamine Maleate
- Fevarin
- Floxyfral
- Dumirox
- Faverin
Novo-Fluvoxamine- Novo-Fluvoxamine
- Novo Fluvoxamine
- Novopharm Brand of Fluvoxamine Maleate
Nu-Fluvoxamine- Nu-Fluvoxamine
- Nu Fluvoxamine
- Nu-Pharm Brand of Fluvoxamine Maleate
- Nu Pharm Brand of Fluvoxamine Maleate
PMS-Fluvoxamine- PMS-Fluvoxamine
- PMS Fluvoxamine
- Pharmascience Brand of Fluvoxamine Maleate
Desiflu- Desiflu
- Declimed Brand of Fluvoxamine Maleate
|
Below are MeSH descriptors whose meaning is more general than "Fluvoxamine".
Below are MeSH descriptors whose meaning is more specific than "Fluvoxamine".
This graph shows the total number of publications written about "Fluvoxamine" by people in this website by year, and whether "Fluvoxamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluvoxamine" by people in Profiles.
-
Lam YW, Gaedigk A, Ereshefsky L, Alfaro CL, Simpson J. CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6. Pharmacotherapy. 2002 Aug; 22(8):1001-6.
-
Kashuba AD, Nafziger AN, Kearns GL, Leeder JS, Gotschall R, Rocci ML, Kulawy RW, Beck DJ, Bertino JS. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther. 1998 Sep; 64(3):257-68.